Trial Profile
A Single-arm, Multiple-Dose, Steady-State, Bioavailability Study With Twice Daily Dosing of Lozanoc (65 mg Itraconazole Capsules, Mayne) Taken Regardless of Food
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Sep 2022
Price :
$35
*
At a glance
- Drugs Itraconazole (Primary)
- Indications Mycoses
- Focus Pharmacokinetics
- Sponsors Mayne Pharma
- 24 Oct 2018 Status changed from not yet recruiting to completed.
- 19 Jul 2016 Planned End Date changed from 1 Dec 2016 to 1 Jan 2017.
- 19 Jul 2016 Planned primary completion date changed from 1 Nov 2016 to 1 Dec 2016.